Cargando…
尼妥珠单抗联合化疗二线及以上治疗晚期肺鳞癌
BACKGROUND AND OBJECTIVE EPIDERMAL: growth factor receptor (EGFR) is commonly overexpressed in lung squamous cell carcinoma and has been associated with impaired prognosis. The aim of this study was to observe the efficacy and safety of nimotuzumab, a anti-EGFR monoclonal antibody, combined with che...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973415/ https://www.ncbi.nlm.nih.gov/pubmed/27760595 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.05 |